|[Frontiers in Bioscience 1, d309-317, October 1, 1996]|
HSP90 - NEWS FROM THE FRONT|
Department of Biology, University of Michigan, Ann Arbor, Michigan, USA
Received 9/9/96; Accepted 9/10/96; On-line 10/1/96
TABLE OF CONTENTS
The 90 kDa heat shock protein Hsp90 is a highly conserved and very abundant protein in the cytosol of both eukaryotic and prokaryotic cells. The main focus in the recent years has been concerned Hsp90's interaction with untransformed steroid receptors and newly synthesized kinases. Within these heterocomplexes, Hsp90 acts in concert with several other heat shock and non heat shock proteins to mediate important regulatory effects. These roles of Hsp90 leave unexplained its high abundance and heat shock regulation. More recently, however, Hsp90 has been identified as an ATP independent molecular chaperone, which binds transiently to folding intermediates in vitro, prevents aggregation and supports the refolding of the intermediates to the native state. The finding that Hsp90 interacts with late, probably highly structured, folding intermediates led to the suggestion that Hsp90 might function as a general chaperone for well structured not yet native polypeptides. This explanation provides the missing link between Hsp90 on the one hand as a highly specialized binding protein and Hsp90 on the other hand as a rather promiscuous molecular chaperone.
It was more than 30 years ago, when Ritossa and coworkers found that an increase in incubation temperature of Drosophila melanogaster larva results in the development of a defined set of new transcription loci on the polytene chromosome (1). Not many people took notice of this important discovery, and it was not until more than 12 years later that the first gene products were identified and the term "heat shock protein" (Hsp) was coined (2). In the following years the heat shock proteins were discovered to be present in all species tested and to be extremely well conserved (reviewed in ref. 3). Even thermophilic organisms, which optimal growth temperature lies between 50° and 90°C have been found to respond sudden temperature upshifts with the overexpression of heat shock proteins. However, while the regulation of heat shock proteins was studied extensively, relatively little was known about their physiological significance (3). It needed the combinational work of many labs to put the pieces together and to revolutionize the protein folding field. The first hint came well before the characterization of heat shock proteins in E. coli with the work of Georgopoulos and collaborators, who discovered that successful lambda phage head assembly depends on the presence of a host-produced protein, subsequently called GroE (4). A few years later, the same group of scientists found another host gene, dnaK, which was shown to be involved in lambda replication (5). That GroE mediated protein folding and assembly is not restricted to phage assembly and DnaK mediated disruption of certain protein-protein interactions is not limited to phage replication (6) became evident with the identification and functional characterization of their eukaryotic homologues. Rubisco binding protein, a chloroplast protein implicated in the assembly of the ribulose 1,5 bisphosphate carboxylase (rubisco) multimeric complex (7) was shown to be closely related to GroEL (8) and the mammalian clathrin uncoating ATPase was identified as Hsc70, the eukaryotic DnaK homologue (9). This was the beginning of the chaperone era and the end of the idea that all proteins reach their specific three dimensional structure spontaneously in the cell (10).
The discovery of folding helper proteins (chaperones) did not contradict Anfinsen's classic theory about protein folding which states that the aquisitation of the specific three dimensional protein structure depends exclusively on the amino acid sequence of the individual protein (11). Chaperones do not change the path of protein folding or the final fold. However, they do keep proteins on the correct folding pathway and prevent unspecific interactions (12), therefore regulating the kinetic competition between folding, specific association and non-specific, irreversible aggregation (13). Aggregation represents a major problem for a folding protein. Since it is a second or higher order reaction it can often be circumvented in vitro by decreasing the protein concentration (14). Cells, however, have a very high concentration of aggregation sensitive folding intermediates at any specific time in a predefined "reaction volume" (15), and therefore need the help of chaperones. Chaperones bind transiently to folding intermediates, keep their free concentration low and suppress otherwise fatal interactions (16).
Aggregation-prone folding intermediates are not unique to newly synthesized polypeptides, but are formed in even higher concentration as a result to dramatic environmental changes such as heat shock and viral infections (17, 18). This explains the high constitutive expression level of heat shock proteins under normal temperature conditions as well as their several-fold overexpression under heat shock conditions (reviewed by 19, 20).
The most prominent heat shock proteins which take care of otherwise irreversibly damaged proteins in eukaryotes are members of the Hsp90 and Hsp70 families. While Hsp70 was one of the first proteins known to function as a molecular chaperone, the function of Hsp90 both under normal and stress conditions has remained elusive. Only very recently, a substantial increase in the understanding has been reported (reviewed in ref. 21).
Until only a few years ago, work on Hsp90 was mainly focused on its interaction with untransformed steroid receptor complexes and newly synthesized tyrosin kinase complexes (reviewed in refs. 22, 21). These specific interactions, however, could not explain why Hsp90 i) represents the most abundant heat shock protein under normal conditions and therefore exceeds the concentration of steroid receptors and kinases by about 1000 fold (23) ii) why it is dramatically upregulated by various conditions such as heat shock (3), iii) why it is essential in yeast (24) and iv) and why it is well conserved in organisms such as prokaryotes, cell compartments such as the endoplasmic reticulum and organelles such as the chloroplasts, where the known substrate proteins are not present (25-27). It has now become clear that Hsp90 functions as a general molecular chaperone in vitro and in vivo, acts in concert with many other heat shock and non heat shock proteins and shows a much broader substrate specificity than originally assumed.
In 1986, two groups independently reported the existence of a non-receptor protein in untransformed steroid receptor complexes (28, 29). This protein was shown to be the dimeric, 90 kDa heat shock protein Hsp90. Following studies showed, that interaction of Hsp90 with hormone free steroid receptors plays a central role in receptor regulation and activation (reviewed by 22, 30). However, it is now clear that Hsp90 is not the only non receptor protein within these heterocomplexes. Hsp90 has been found to be associated with at least 7 other partner proteins in hormone free receptor heterocomplexes (21, 22, 31-33). This complex formation is the prerequisite for hormone binding. After binding of the ligand and dissociation of the heterocomplex into the individual proteins, the hormone bound receptor undergoes various modifications and interactions, which finally lead to its activation as transcription factor. Central to its role in receptor regulation is the interaction of Hsp90 with the signal domain (hormone binding domain) of the aporeceptor (34). This domain is responsible for hormone binding in the presence of ligands as well as for the inactivation of the DNA binding domain of the receptor in the absence of ligands (35). Based on in vitro experiments it seems reasonable to conclude that the function of Hsp90 is not simply to mediate the inactivation of steroid-receptors in the absence of the ligand but rather to keep receptors in an activatable state (30). The interaction of Hsp90 with hormone free receptors induces the formation of a high affinity ligand binding conformation within the hormone binding domain and is also important for subsequent maintenance of this conformation (30). Conformational changes between the hormone and DNA binding domain of the receptor upon Hsp90 association and dissociation have been demonstrated (36).
Since the additional proteins of the heterocomplex have been identified only very recently, little is known about their role in receptor regulation (31, 32). To elucidate their function, cell-free systems have been established to study the influence of the various members on successful heterocomplex assembly. In the case of the progesterone receptor, Hsp90 and at least 7 other proteins are involved (32): Hsp70, Hip, Hop, immunophilins and p23. Hsp70 promotes protein folding and might "prepare" the conformation of steroid-receptors for Hsp90 binding (37). Hip (Hsp70 interacting protein), also called p48, seems to regulate the ATPase activity of Hsp70 (38). The role of Hop (Hsp70-Hsp90 organizing protein), better known as p60, is still very much unknown, except that it has been found in complex with Hsp90, Hsp70 and Hip also in the absence of untransformed receptors (39). Another group of proteins involved in heterocomplex assembly are the three immunophilins FKBP54, FKBP52 (Hsp56, p59) and Cyp40. Since all three isomerases compete for the single common immunophilin binding site on Hsp90, only one of them is found in any given heterocomplex but all three of them are present in heterocomplex preparations (40, 41). Curiously, peptidyl prolyl isomerase activity appears not to be required for complex formation since the presence of the respective immunosuppressor does not interfere with the complex formation (22). Finally, an unique protein called p23 copurifies with Hsp90 from all tissues tested and can be reconstituted into a functional complex with Hsp90 and immunophilins in vitro in an ATP-dependent manner (42, 43). The origin of the ATP-dependence is still unclear, but transient involvement of Hsp70 seems a reasonable explanation.
The discovery that Geldanamycin specifically disrupts certain interactions within the Hsp90 complex (44) led to a detailed working model about the series of events taking place during the superchaperone-progesterone receptor heterocomplex assembly (see Figure 1) (adapted from ref. 32).
Figure 1: Working model for the dynamic and transient interactions of progesterone receptor with the Hsp90 superchaperone complex (adapted from ref. 32). Figure courtesy of David Smith. Step 1: ATP-dependent formation of an early complex between Hsp70 and either newly synthesized or folded progesterone receptor (PR). Step 2: Formation of an intermediate complex between PR and a preformed complex consisting of Hsp90, Hop, Hsp70 and Hip. It is still unclear at what time and stage Hip enters the complex and whether the formation of the early complex is a necessary prerequisite for step 2. Step 3: Formation of the mature complex between PR and a preformed complex of Hsp90, immunophilin (either one of the three immunophilins FKBP54, FKBP52 or Cyp40) and p23. The PR is now active (indicated by the solid black line). After dissociation of the complex, PR can either bind hormone and undergo activation as transcription factor, or in the absence of ligands interact with Hsp70 to start the new cycle over again.
The second group of proteins, with which Hsp90 forms stable complexes are certain viral and cellular protein kinases. Hsp90 has been shown to associate with newly synthesized, possibly aggregation sensitive tyrosine kinases until the kinase becomes attached to the plasma membrane (45, 46). Hsp90 clearly plays an important role in the maturation of these kinases. In this context it has been demonstrated that Hsp90 and the partner protein p50 form stable complexes with temperature sensitive pp60v-src mutants under non-permissive temperatures. Temperature shifts into the permissive range result in the dissociation of the complex and insertion of pp60v-src into the plasma membrane (47). Furthermore it has been shown, that the number of active, membrane associated pp60v-src molecules is lower in cells expressing low levels of Hsp90 (48). And recently it has been demonstrated that benzochinon ansamycins like Geldanamycin (GA) result in lower levels of active tyrosine kinases since the interaction of GA with Hsp90 leads to the disruption of Hsp90- pp60v-src complexes. This appears to result in an increased proteolytic turnover of pp60v-src (32,44).
The observation that Hsp90 interacts with pp60v-src but not with the closely related cellular homologue pp60v-src resulted in the speculation that the substrate specificity of Hsp90 is rather narrow (48). However, only recently it has been demonstrated, that Hsp90 is able to interact with both viral and cellular members of certain tyrosin kinases (49). This makes it more reasonable to assume, that differences in interactions with Hsp90 are based on differences in the folding pathway and stability of the respective kinases rather then on the substrate specificity of Hsp90 (21, 49).
The partner proteins of Hsp90 which are present in receptor complexes have also been identified as members of Hsp90-protein kinase complexes, as well as members of heat shock factor 1-Hsp90 complexes (33, 50), suggesting that they may play a general role in Hsp90 function. The function of p50, a protein, which represents the first partner protein of Hsp90 identified (45) and which has so far only been detected in Hsp90-kinase complexes remains to be established.
Chaperones function by their ability to recognize and transiently bind aggregation-prone folding intermediates, therefore suppressing non-specific aggregation and increasing the yield of proper folded proteins (16). The chaperone activity of proteins has been investigated in vitro by studying their influence on substrate proteins which are unable to refold after denaturation due to aggregation processes. Figure 2 shows the influence of Hsp90 on the refolding of chemically denatured citrate synthase, a chaperone model substrate, by monitoring aggregation (51).
Figure 2: Influence of Hsp90 on the aggregation of refolding citrate synthase (51).
Denatured citrate synthase in the absence of added chaperones spontaneously aggregates upon dilution into renaturation buffer (52). Within a few seconds, light scattering can be detected. In the presence of stoichiometric amounts of Hsp90, aggregation is significantly suppressed, suggesting that Hsp90 binds to these aggregation sensitive folding intermediates. Therefore, Hsp90 partitions a larger number of molecules into a productive folding pathway, thus allowing a higher number of molecules to reach the active, native state. Hsp90 influences the folding and activity of a number of different non-native proteins, suggesting that Hsp90 functions in vitro as a molecular chaperone with rather broad substrate specificity. These studies included the finding that Hsp90 is able to chaperone casein kinase II by preventing unproductive aggregation (53) and that the presence of Hsp90 or equally well just a C-terminal fragment of Hsp90 resulted in twofold more active muscle specific protein MyoD (54, 55). In none of these cases has a stable interaction between isolated Hsp90 and its substrate proteins been detected. The folding kinetics of citrate synthase in the presence of Hsp90 instead suggested that reactivation of the enzyme occurs via successive binding-release-rebinding cycles with folding intermediates. After the release from Hsp90, the intermediates face at least three possible routes (Figure 3): they can either refold to the native state, being therefore no longer substrate of Hsp90, rebind to Hsp90 or interact with other folding intermediates to form aggregates (21). Which route they take will depend on the microscopic rate constants of folding and association as well as on the concentration of folding intermediates and Hsp90. To favor rebinding to Hsp90 and prevent aggregation, an excess of Hsp90 is required. This excess is guaranteed by the high abundance of Hsp90 in the cell (51). In the case of citrate synthase, casein kinase and MyoD transient interactions with Hsp90 are sufficient to promote proper refolding. (-galactosidase, however, seems to need the combined action of Hsp90, Hsp70 and Hdj-1 to regain activity (56). Folding conditions, folding rates and the nature of the folding intermediates probably determine the need of specific folding helper proteins. Under permissive folding conditions as in the case for citrate synthase, folding may take place simply after the release of Hsp90. Rebinding to Hsp90 will be only achieved using high amounts of Hsp90 (51). Under less permissive folding conditions, however, where spontaneous folding rates are comparatively slow, refolding of the enzyme becomes outcompeted by the rebinding to Hsp90 and the protein appears to be stably associated with Hsp90 in a folding competent state. This might be the case for (-galactosidase, where the ATP-dependent chaperone activity of Hsp70 and Hdj-is required to support the functional refolding of the enzyme.
Figure 3: Working model for the interaction of Hsp90 with unfolded substrate proteins.
According to this model, the functional mechanism of Hsp90 is very similar to the mechanism described for the GroE system (summarized in ref. 23). Under permissive folding conditions, the presence of GroEL alone is often sufficient to promote refolding of certain substrate protein by iterative cycles of binding, release and rebinding (57-59). Under suboptimal or non permissive conditions, however, the additional help of either ATP or ATP and GroES for efficient refolding is required, otherwise the substrate protein stays associated with GroEL in an apparently stable complex maintained in a folding competent state (60). The role that ATP plays in this reaction was recently illuminated by showing that ATP decreases the on-rate of rebinding of the substrate protein to GroEL by three orders of magnitude (61). The prolonged time in which the folding intermediate is not associated with GroEL allows refolding to occur under conditions where the folding rate of the substrate protein is rather slow. Under non permissive conditions, however, where spontaneous refolding is unlikely, the additional presence of GroES is required (summarized in ref. 23).
For some time the ATP independence of Hsp90 action in vitro has been controversial (21). Two groups have reported ATP binding and ATPase activity of Hsp90 (62-65). However, careful use of a number of techniques with the appropriate controls has now ruled out ATP binding or ATPase activity for Hsp90 (66). It remains possible that proteins associated with Hsp90 may have these activities.
Hsp90 is a very abundant protein under normal conditions, but its concentration increases even more upon sudden temperature upshifts (3). Although an important fact, only very few in vivo approaches have been undertaken to study the function of Hsp90 under heat shock conditions in the cell. It has been demonstrated, that i) deleting E. coli Hsp90 results in a slight growth disadvantage at elevated temperatures (67), ii) that yeast Hsp90 is essential at any temperature (24) and iii) that decreasing the high intracellular Hsp90 concentration leads to an increased mortality of mammalian cells at elevated temperatures (68). To gain more insight in the protective role Hsp90 plays under conditions where unfolding and subsequently aggregation of polypeptides occurs, the influence of isolated Hsp90 on thermally unfolding proteins has been studied. In these in vitro studies it has been shown, that both eu- and prokaryotic Hsp90 binds transiently to thermally unfolding intermediates of the model substrate citrate synthase, thereby apparently stabilizing the enzyme and suppressing aggregation (69, 70). In the presence of Hsp90, folding intermediates are kept significantly longer in a folding competent state (69). Experiments which study the refolding of thermally inactivated firefly luciferase revealed the additional need for Hsp70 and ATP for efficient refolding of luciferase (71) similar to what was seen with chemically unfolded (-galactosidase. It is likely to assume, that Hsp90 keeps luciferase in a folding competent state, while Hsp70 and ATP promotes the functional renaturation of luciferase. Taken together these findings suggest that Hsp90 plays a general role in protein folding and assembly processes. Depending on the substrate protein, Hsp90 might act in conjunction with other chaperones and helper proteins.
At first glance, Hsp90's actions seem very contradictionary: in vitro Hsp90 presents itself as being a rather promiscuous chaperone, interacting with a broad range of folding and unfolding intermediates, whereas in vivo Hsp90 has been found associated only with a small subset of distinct substrate proteins. On closer examination, however, many similarities become apparent and the conclusion may be drawn that both the in vitro and in vivo functions of Hsp90 are based on the same mechanism: the transient and dynamic interaction of Hsp90 with non-native proteins.
All the known substrate proteins of Hsp90 seem to be in their non-native state yet possess a substantial amount of secondary and tertiary structure. This has been clearly demonstrated for thermally unfolding citrate synthase and is well established for kinases and steroid receptors. Hsp90 has been shown to interact with very early unfolding intermediates of citrate synthase. These intermediates are still in their dimeric state and have probably most of their native intramolecular contacts left. The same might also apply for casein kinase II, another in vitro substrate of Hsp90. Native casein kinase II precipitates probably due to partial unfolding and exposing "interactive" surfaces upon incubation in low salt buffer unless Hsp90 is present to bind the intermediates (53). The molecular basis of Hsp90's interaction with untransformed steroidreceptors has being discussed recently in a similar context as either i) regulating the oligomerisation state of receptors, ii) protecting receptors from proteolysis or iii) stabilizing their alternate conformational states (33). Taken together, a substantial amount of probably native like structure characterizes all known substrate proteins of Hsp90 and provides a link between the in vivo and in vitro substrate specificities of Hsp90.
Moreover, the mechanistical features of Hsp90 action with the different substrate proteins appear very similar. In either case, interactions with Hsp90 involve multiple rounds of binding, release and rebinding of the substrate protein. But then the question arises why no other proteins except steroidreceptors and kinases have been identified as in vivo substrates of Hsp90? The reason could be based on the nature of the two substrate proteins rather than on the substrate specificity of Hsp90. Steroid receptors and kinases represent polypeptides, where folding to the native state requires either specific ligands or association with the membrane, respectively. Highly structured, long-lived folding intermediates are therefore part of their folding pathway. In the absence of ligands or membranes, the equilibrium of folding is on the side of the folding intermediate and dissociation of Hsp90 provokes immediate rebinding. Hsp90 appears to be stably associated with the folding intermediates, keeps the polypeptides in a folding competent state and allows successful co-immunoprecipitation. Presence of ligands shifts the folding equilibrium towards the native state and rebinding to Hsp90 will not occur any longer. This folding pathway is in sharp contrast to the pathway of most other cellular proteins, which fold directly to the native state. This implies that the folding equilibrium is far shifted towards the native state and only transient associations with Hsp90 will be observed. The ATP independence of Hsp90's general chaperone activity fits nicely into this picture, since no major structural rearrangement are requested from this folding helper protein. The high abundance of Hsp90, however, is necessary for its action and guaranteed, since Hsp90 represents one of the most prominent proteins in the cytosol of eukaryotic cells.
I thank Johannes Buchner and James Bardwell for many stimulating discussions and for critically reading the manuscript. I also thank David Smith for providing me with Figure 1. The work is supported by a fellowship of the Deutsche Forschungsgemeinschaft (DFG).
1. FA Ritossa: A new puffing pattern induced by a temperature shock and DNP in Drosophila. Experientia 18, 571-573, (1962)
2. A Tissiéres, HK Mitchell & U Tracy: Protein synthesis in salivary glands of Drosophila melanogaster: relation to chromosomal puffs. J Mol Biol 84, 389-398, (1974)
3. SC Lindquist & EA Craig: The heat shock proteins. Ann Rev Genet 22, 631-677, (1988)
4. C Georgopoulos, RW Hendrix, SR Casjens & AD Kaiser: Host participation in bacteriophage lambda head assembly. J Mol Biol 76, 45-60, (1973)
5. CP Georgopoulos: A new bacterial gene (groPC) which affects lambda DNA replication. Mol Gen Genet 151, 35-39, (1977)
6. T Yamamoto, J McIntyre, SM Sell, C Georgopoulos, D Skowyra & M Zylicz: Enzymology of the pre-priming steps in lambda dv DNA replication in vitro. J Biol Chem 262, 7996-7999, (1987)
7. R Barraclough & RJ Ellis: Protein synthesis in chloroplasts. XI. Assembly of newly synthesized large subunits into ribulose bisphosphate carboxylase in isolated intact chloroplasts. Biochim Biophys Acta 608, 19-31 (1980)
8. SM Hemmingson, C Woolford, SM Van der Vies, K Tilly, DT Dennis, GC Georgopoulos, RW Hendrix & RJ Ellis: Homologous plant and bacterial proteins chaperone oligomeric protein assembly. Nature 333, 330-334, (1988)
9. E Ungewickell: The 70 kDa mammalian heat shock proteins are structurally and functionally related to the uncoating protein that releases clathrin triskelions from coated vesicles. EMBO J 4, 3385-3391, (1985)
10. RJ Ellis: Proteins as molecular chaperones. Nature 328, 378-379, (1987)
11. CB Anfinsen: Principles that govern the folding of protein chains. Science 181, 223-230, (1973)
12. RJ Ellis & SM Van der Vies: Molecular chaperones. Ann Rev Biochem 60, 321-347, (1991)
13. R Jaenicke: Protein folding and association: in vitro studies for self-organization and targeting in the cell. Curr Top Cell Regul 34, 209-314, (1996)
14. T Kiefhaber, R Rudolph, H-H Kohler & J Buchner: Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Bio/Technol 9, 825-829, (1991)
15. GH Lorimer: A quantitative assessment of the role of the chaperonin proteins in protein folding in vivo. Faseb J 10, 5-10, (1996)
16. R Jaenicke & J Buchner: Protein folding: From "unboiling an egg" to "catalysis of folding". Chemtract: Biochem Mol Biol 4, 1-30, (1993)
17. S Munro & H Pelham: What turns on heat-shock genes? Nature 317, 477-478, (1985)
18. M Pinto, M Morange & O Bensaude: Denaturation of proteins during heat shock. in vivo recovery of solubility and activity of reporterenzymes. J Biol Chem 266, 13941-13946, (1991)
19. MJ Gething & J Sambrook: Protein folding in the cell. Nature 355, 33-45, (1992)
20. JP Hendrick & F-U Hartl: Molecular chaperone functions of heat shock proteins. Ann Rev Biochem 62, 349-384, (1993)
21. U Jakob & J Buchner: Assisting spontaneity-the role of Hsp90 and small Hsps as molecular chaperones. Trends in Biochem Sci 19, 205-211, (1994)
22. WB Pratt: The role of heat shock proteins in regulating the function, folding and trafficking of the glucocorticoid receptor. J Biol Chem 268, 21455-21458, (1993)
23. J Buchner: Supervising the fold: functional principles of molecular chaperones. Faseb J 10, 10- 19, (1996)
24. KA Borkovich, FW Farrelly, DB Finkelstein, J Taulien & S Lindquist: Hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Mol Cell Biol 9, 3919-3930, (1989)
25. Bardwell, J.C.A. & Craig, E.A. (1987) Eukaryotic Mr 83,000 heat shock protein has a homologue in Escherichia coli. Proc Natl Acad Sci USA 84, 5177-5181, (1987)
26. PK Sorger & HRB Pelham: The glucose-regulated protein grp94 is related to heat shock protein hsp90. J Mol Biol 194, 341-344, (1987)
27. G Schmitz, M Schmidt & J Feierabend: Characterization of a plastid-specific HSP90 homologue: identification of a cDNA sequence, phylogenetic descendence and analysis of its mRNA and protein expression. Plant Mol Biol 30, 479-92, (1996)
28. J-M Renoir, T Buchou & E-E Baulieu: Involvement of a non-hormone binding 90-kilodalton protein in the nontransformed 8S form of the rabbit uterus progesterone receptor. Biochemistry 25, 6405-6413, (1986)
29. ER Sanchez, PR Housley & WB Pratt: The molybdate-stabilized glucocorticoid binding complex of L-cells contains a 98-100 Kdalton steroid binding phosphoprotein and a 90 Kdalton nonsteroid-binding phosphoprotein that is part of the murine heat-shock complex. J Steroid Biochem 24, 9-18, (1986)
30. DF Smith: Dynamics of heat shock protein 90-progesterone receptor binding and the disactivation loop model for steroid receptor complexes. Mol Endocrinol 7, 1418-1429, (1993)
31. DF Smith & DO Toft: Steroid receptors and their associated proteins. Mol Endocrinol 7, 4-11, (1993)
32. DF Smith, L Whitesell, SC Nair, S Chen, V Prapapanich & RA Rimerman: Progesterone receptor structure and function altered by geldanamycin, an Hsp90 binding agent. Mol Cell Biol 15, 6804-6812, (1995)
33. SC Nair, ET Toran, RA Rimerman, S Hjermstad, TS Smithgall & DF Smith: A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosin kinase, heat shock transcription factor HSF1, and the arylhydrocarbon receptor. Cell Stress and Chaperones, in press
34. SP Bohen & RI Yamamoto: Modulation of steroid receptor signal transduction by heat shock proteins. In: The Biology of Heat Shock Proteins and Molecular Chaperones, Eds: RI Morimoto, A Tissiéres & C Georgopoulos, 313-334, CSHL Press, Cold Spring Harbour, New York, (1994)
35. PJ Godowski, S Rusconi, R Miesfeld & KR Yamamoto: Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature 326, 365-368, (1987)
36. LF Stancato, AM Silverstein, C Gitler, B Groner & WB Pratt: Use of the thiol-specific derivatizing agent N-iodoacetyl-3-[125I] iodotyrosine to demonstrate conformational differences between the unbound and hsp90-bound glucocorticoid receptor hormone binding domain. J Biol Chem 271, 8831-8836 (1996)
37. KA Hutchison, KD Dittmar, MJ Czar & WB Pratt: Proof that Hsp70 is required for assembly of the glucocorticoid receptor into a heterocomplex with Hsp90. J Biol Chem 269, 5043-5049, (1993)
38. J Hoehfeld, Y Minami & F-U Hartl: Hip, a new cochaperone involved in the eukaryotic Hsc70/Hsp40 reaction cycle. Cell 83, 589-598, (1995)
39. DF Smith, WP Sullivan, TN Marion, K Zaitsu, B Madden, DJ McCormick & DO Toft: Identification of a 60 kDa stress-related protein, p60, which interacts with Hsp90 and Hsp70. Mol Cell Biol 13, 869-876, (1993)
40. JK Owens-Grillo, K Hoffmann, KA Hutchison, AW Yem, MR Deibel, RE Handschumacher & WB Pratt: The cyclosporin A-binding immunophilin Cyp-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J Biol Chem 270, 20479-20484, (1995)
41. T Ratajczak & A Carrello: Cyclophilin 40 (CyP-40), mapping of its hsp90 binding domain and evidence that FKBP52 competes with CyP-40 for hsp90 binding. J Biol Chem 271, 2961-2965, (1996)
42. JL Johnson, TG Beito, CJ Kreo & DO Toft: Characterisation of a novel 23-kilodalton protein of unactive progesterone receptor complexes. Mol Cell Biol 14, 1956-1963, (1994)
43. JL Johnson & DO Toft: A novel chaperone complex for steroid receptors involving heat shock protein, immunophilins and p23. J Biol Chem 269, 24989-24993, (1994)
44. L Whitesell, EG Mimnaugh, B De Costa, CE Myers & LM Neckers: Inhibition of heat shock protein Hsp90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: Essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA 91, 8324-8328, (1994)
45. JS Brugge, E Erikson & RL Erikson: The specific interaction of the Rous sarcoma virus transforming protein, pp60src, with two cellular proteins. Cell 25, 363-372, (1981)
46. JS Brugge, W Yuonemoto & D Darrow: Interaction between the Rous sarcoma virus transforming protein and two cellular phosphoproteins: analysis of the turnover and distribution of this complex. Mol Cell Biol 4, 2697-2704, (1983)
47. JS Brugge: Interaction of the Rous sarcoma virus protein pp60src with the cellular proteins pp50 and pp90. Curr Top Microbiol Immunol 123, 1-22, (1986)
48. Y Xu & SC Lindquist: Heat-shock protein Hsp90 governs activity of pp60v-src kinase. Proc Natl Acad Sci USA 90, 7074-7078, (1993)
49. SD Hartson & RL Matts: Association of Hsp90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function. Biochemistry 33, 8912-8920, (1994)
50. ML Whitelaw, K Hutchison & GH Perdew: A 50-kDa protein complexed with the 90-kDa heat shock protein (Hsp90) is the same protein complexed with pp60v-src in cells transformed by the Rous sarcoma virus. J Biol Chem 266, 16436-16440, (1991)
51. H Wiech, J Buchner, R Zimmermann & U Jakob: Hsp90 chaperones protein folding in vitro. Nature 358, 169-170, (1992)
52. J Buchner, M Schmidt, M Fuchs, J Jaenicke, R Rudolph, FX Schmid & T Kiefhaber: GroE facilitates refolding of citrate synthase by suppressing aggregation. Biochemistry 30, 1586-1591, (1991)
53. Y Miyata & I Yahara: The 90-kDa heat shock protein, Hsp90, binds and protects casein kinase II from self-aggregation and enhances its kinase activity. J Biol Chem 267, 7042-7047, (1992)
54. R Shaknovich, G Shue & S Kohtz: Conformational activation of a basic helix-loop-helix protein (MyoD1) by the C-terminal region of the murine Hsp90 (Hsp84). Mol Cell Biol 12, 5059-5068, (1992)
55. G Shue & DS Kohtz: Structural and functional aspects of basic helix-loop-helix protein folding by heat-shock protein 90. J Biol Chem 269, 2707-2711, (1994)
56. B Freeman & R Morimoto: The human cytosolic molecular chaperones Hsp90, Hsp70 (Hsc70), and Hdj-1 have distinct roles in recognition of a non-native protein and protein refolding. EMBO J 15, 2969-2979, (1996)
57. MJ Todd, P Viitanen & GH Lorimer: Dynamics of the chaperonin ATPase cycle. Implications for facilitated folding. Science 265, 659-666, (1994)
58. J Weissmann, Y Kashi, WA Fenton & AL Horwich: GroEL-mediated folding proceeds by multiple rounds of binding and release of nonnative forms. Cell 78, 693-702, (1994)
59. H Lilie & J Buchner: Interaction of GroEL with a highly structured folding intermediate: iterative binding cycles do not involve unfolding. Proc Natl Acad Sci USA 92, 8100-8104, (1995)
60. M Schmidt, J Buchner, M Todd, G Lorimer & P Viitanen: On the role of GroES in the chaperone-assisted folding reaction: three case studies. J Biol Chem 269, 10304-10311, (1994)
61. H Sparrer, H Lilie & J Buchner: Dynamics of the GroEL-protein complex: effects of nucleotides and folding mutants. J Mol Biol 258, 74-87, (1996)
62. P Csermely & CR Kahn: The 90-kDa heat shock protein (hsp90) possesses an ATP binding site and autophosphorylating activity. J Biol Chem 266, 4943-4950, (1991)
63. P Csermely, J Kajtar, M Hollosi, G Jalsovszky, S Holly, R Kahn, P Gergerly, C Söti, K Mihaly & J Somogyi: ATP induces a conformational change of the 90-kDa heat shock protein (hsp90). J Biol Chem 268, 1901-1907, (1993)
64. K Nadeau, MA Sullivan, M Bradley, DM Engman & CT Walsh: 83-kilodalton heat shock proteins of trypanosomes are potent peptide-stimulated ATPases. Protein Sci 1, 970-9 (1992)
65. K Nadeau, A Das & CT Walsh: Hsp90 chaperonins possess ATPase activity and bind heat shock transcription factors and peptidyl prolyl isomerases. J Biol Chem 268, 1479-1487 , (1993)
66. U Jakob, T Scheibel, S Bose, J Reinstein & J Buchner: Assessment of the ATP binding properties of Hsp90. J Biol Chem 271, 10035-10041, (1996)
67. JCA Bardwell & EA Craig: Ancient heat shock protein is dispensable. J Bacteriol 170, 2977-2983, (1988)
68. GS Bansal, PM Norton & DS Latchman: The 90-kDa heat shock protein protects mammalian cells from thermal stress, but not from viral infection. Exp Cell Res 195, 303-306, (1991)
69. U Jakob, H Lilie, I Meyer & J Buchner: Transient interaction of Hsp90 with early unfolding intermediates of citrate synthase-implications for heat shock in vivo. J Biol Chem 270, 7288-7294, (1995)
70. U Jakob., I Meyer, H Buegl, S Andre, JCA Bardwell & J Buchner: Structural organization of pro- and eukaryotic Hsp90. Influence of divalent cations on structure and function. J Biol Chem 270, 18158-18164, (1995)
71. RJ Schumacher, R Hurst, WP Sullivan, NJ McMahon, DO Toft & RL Matts: ATP-dependent chaperoning activity of reticulocyte lysate. J Biol Chem 269, 9493-9499, (1994)